Peptide Profile
Enalapril
The blood pressure champion that helped millions breathe easier and live longer
Dose Range
2.5 mg-40 mgmg
Frequency
Once daily
Route
Oral tablet
Cycle Length
Ongoing/indefinite
Onset
Moderate (1-2 weeks)
Evidence
Strong
Compound Profile
Scientific & Efficacy Data
C20H28N2O5
Molecular Formula
376.4 g/mol
Molecular Weight
Enalapril: 1 hour; Enalaprilat (active form): 11 hours effective half-life
Half-Life
Approximately 60% oral bioavailability when taken by mouth
Bioavailability
75847-73-3
CAS #
5388962
PubChem ID ↗
Developed By · Research ongoing
Academic research consortium
Multiple research institutions
Primary Benefits
Powerfully reduces blood pressure and strengthens the failing heart, proven in landmark studies to save lives
Prevents dangerous complications like heart attacks and strokes when taken consistently over years
Helps you exercise more, breathe easier, and enjoy daily activities without heart limitations
Amino Acid Sequence
Not a natural peptide; synthetic pharmaceutical compound derived from peptide researchDosing
How much
do I take?
Timing
Best time to take
Take Enalapril at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Enalapril can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Enalapril should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
Decrease if
- -Side effects are bothersome or impacting daily life despite management strategies
- -You experience any signs of an adverse reaction
- -Lab results indicate the need for dose reduction
- -Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
Managing hypertension to prevent serious complications
Enalapril is particularly well-suited for individuals focused on managing hypertension to prevent serious complications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Treating heart failure and improving survival rates
Enalapril is particularly well-suited for individuals focused on treating heart failure and improving survival rates. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Protecting organs from damage caused by high blood pressure
Enalapril is particularly well-suited for individuals focused on protecting organs from damage caused by high blood pressure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×Pregnancy (causes serious fetal harm)
- ×History of angioedema with ACE inhibitors
- ×Severe renal dysfunction
- ×Concurrent use with certain other blood pressure medications
- ×Potassium supplementation without medical supervision
Use with caution if
- !You are taking other medications—discuss potential interactions with your healthcare provider
- !You have a history of liver or kidney disease
- !You are elderly or have multiple medical conditions
- !You are planning surgery in the near future—inform your surgeon about Enalapril use
- !You have any chronic health conditions that require regular monitoring
Administration
How do I
use it?
Reconstitution
What you need
- •Enalapril in its prescribed form
- •Clean, dry storage container
- •Measuring device if applicable (oral syringe, measuring cup)
- •Calendar or reminder app for dosing schedule
Injection
Route
Enalapril is administered Oral tablet—no injection required
Best sites
- •Not applicable—this is not an injectable formulation
Technique
- 1.Follow the specific administration instructions for your Enalapril formulation
- 2.Take or apply as directed by your healthcare provider
- 3.Store properly between uses according to package instructions
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
Enalapril is an FDA-approved ACE inhibitor with safety data spanning over 40 years of clinical use and post-market surveillance in millions of hypertensive patients. Persistent dry cough occurs in 10-20% of patients, caused by kinase II inhibition and bradykinin accumulation. Hyperkalemia is a serious risk, particularly in renal impairment, diabetes, or concurrent NSAID/potassium-sparing diuretic use—potassium monitoring is essential. Angioedema (0.1-0.2%) is a rare but life-threatening emergency, absolute contraindication for future ACE inhibitor use. Hypotension can occur in volume-depleted patients or those on concurrent vasodilators. Acute kidney injury risk exists in patients with bilateral renal artery stenosis or single kidney. Fetal teratogenicity is well-documented in pregnancy.
Enalapril was studied in large Phase 3 trials including landmark SAVE and AIRE trials demonstrating cardiovascular mortality benefits in heart failure and post-MI patients. Post-market surveillance spans 40+ years with extensive safety data from millions of treated patients globally, making it one of the most thoroughly characterized antihypertensive agents. Comparative safety data with other ACE inhibitors and ARBs provides comprehensive risk-benefit framework.
Common Side Effects
Experienced by some users
Dry cough
Annoying but harmless persistent cough from increased bradykinin in airways. Affects 15-20% of ACE inhibitor users. Usually appears within days of starting but can develop weeks later. Worsens when lying flat.
Management: Sip water frequently to coat throat. Use sugar-free lozenges (honey or zinc help). Try dextromethorphan cough suppressant if severe. Avoid ACE irritants like spicy food. Sleep with head elevated on extra pillow. If intolerable after 2-4 weeks, switch to ARB (e.g., losartan) which doesn't cause this effect.
Dizziness
Orthostatic hypotension—blood pressure dropping too rapidly on standing, especially from lying/sitting position. Most common in first 1-2 weeks or after dose increases. More likely if dehydrated or on diuretics.
Management: Rise slowly from bed or chair—sit up for 30 seconds before standing. Stay well-hydrated (drink 2-3 liters water daily unless restricted). Avoid sudden position changes or standing for long periods. Eat small salty snacks if approved by provider. Compression stockings help. Symptoms usually resolve within 2-3 weeks as body adjusts.
Fatigue
Mild tiredness that often improves as your body adjusts. Results from lower blood pressure reducing cardiac workload—a sign the drug is working. Usually most noticeable in first 1-2 weeks and gradually improves.
Management: Gradual increase in activity level helps build tolerance. Small frequent meals prevent energy crashes. Ensure adequate sleep (7-9 hours). Check iron and B12 levels as deficiency worsens fatigue. Avoid sudden exertion before body adapts. Caffeine in moderation is acceptable. Fatigue typically resolves by week 3-4.
Hyperkalemia
ACE inhibitors reduce aldosterone, causing kidneys to retain potassium. Risk increases with kidney disease or concurrent potassium-sparing diuretics. Potassium typically rises 0.3-0.5 mEq/L. Dangerous only if becomes severe (>5.5 mEq/L).
Management: Get baseline potassium test before starting; recheck at 1 week, 4 weeks, then every 3-6 months. Avoid potassium supplements and salt substitutes (KCl). Limit high-K foods moderately (bananas, oranges, leafy greens less frequent). NSAIDs increase K retention—use sparingly. If level rises above 5.5, notify provider immediately—may need to reduce dose or add diuretic.
Angioedema
Rare but serious swelling of face, lips, tongue, or throat from elevated bradykinin in tissue. Can occur hours to weeks after starting. More common in African ancestry and smokers. Affects <1% of users but requires immediate action.
Management: This is a MEDICAL EMERGENCY—go to ER immediately if swelling affects breathing or throat. Milder facial/lip swelling: stop enalapril immediately, do not restart. Emergency room will give IV diphenhydramine and corticosteroids. Switch to ARB (losartan) or other antihypertensive class. Never rechallenge with ACE inhibitors.
Stop and Seek Help If
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Enalapril
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Enalapril should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
- ✓Additive blood pressure-lowering effects make this combo highly effective for hypertension
- ✓Work synergistically to improve heart function and blood pressure control in heart failure
- ✓Commonly combined in heart failure treatment with proven safety and effectiveness
With medications
- !Potassium supplements - Enalapril increases potassium levels; adding supplements can cause dangerous hyperkalemia
- !NSAIDs (like ibuprofen) - May reduce the blood pressure-lowering effect and increase kidney problems
- !Lithium - Enalapril can cause lithium to build up to toxic levels in the body
With supplements
- ✓Multivitamins - Generally safe to take alongside Enalapril. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does it
work?
Evidence Level
Strong human trials
What to Expect
15 minutes
What you might notice
- •Enalapril enters your bloodstream from your stomach
- •Individual responses to Enalapril may vary during this period
What's normal
- •Initial response to Enalapril is beginning at the cellular level
- •Different individuals experience Enalapril's onset at different rates
- •Transient systemic effects from initial Enalapril exposure are common
What's next
- →Maintain consistent Enalapril administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
1 hour
What you might notice
- •Blood pressure starts dropping
- •Your body converts enalapril to enalaprilat
What's normal
- •Enalapril is achieving sufficient receptor engagement
- •Initial mechanism of Enalapril is taking effect
- •Early transient effects from Enalapril administration are resolving
What's next
- →Maintain consistent Enalapril administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
3-4 hours
What you might notice
- •Peak effect reached
- •Your blood pressure is at its lowest point for the day
What's normal
- •Enalapril is achieving sufficient receptor engagement
- •Initial mechanism of Enalapril is taking effect
- •Early transient effects from Enalapril administration are resolving
What's next
- →Maintain consistent Enalapril administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
11 hours
What you might notice
- •Effective half-life—blood enalapril concentration is about 50% of peak
- •Individual responses to Enalapril may vary during this period
What's normal
- •Enalapril is achieving sufficient receptor engagement
- •Initial mechanism of Enalapril is taking effect
- •Early transient effects from Enalapril administration are resolving
What's next
- →Maintain consistent Enalapril administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
24 hours
What you might notice
- •Still working! Blood pressure remains controlled
- •Ready for your next dose
What's normal
- •Enalapril response patterns are emerging
- •Initial Enalapril response is consistent with mechanism expectations
- •Early tolerance development to Enalapril is not expected
What's next
- →Assess whether Enalapril response aligns with expectations
- →Plan next steps based on initial Enalapril tolerance and response
- →Establish baseline monitoring for Enalapril response tracking
Signs It's Working
Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Enalapril over time
- ✓Reduction in symptom frequency or severity
General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key Research
"Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors in Heart Failure Patients With Reduced Ejection Fraction: A Cross Sectional Study on Implications for Guideline-Targeted Therapy"
Research investigators, 2020
Finding: Enalapril and other ACE inhibitors remain foundational for heart failure treatment with reduced ejection fraction. Proper dose optimization is essential for achieving guideline-recommended therapy targets and improving patient outcomes.
View Study"Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial"
Research investigators, 2020
Finding: The PARACHUTE-HF trial compared enalapril with newer combination therapy in a unique disease population. Enalapril continues to serve as an important standard therapy with sustained hemodynamic benefits in heart failure management.
View Study"Untargeted metabolic analysis in serum samples reveals metabolic signature in children with congenital heart failure on enalapril therapy"
Research investigators, 2020
Finding: Metabolic profiling identified distinct signatures in children responding to enalapril therapy, with specific metabolites predicting treatment response. This analysis revealed improved outcomes in responders with more severe baseline heart failure.
View StudyFrequently Asked Questions